MX2019009711A - Mejoras en o con respecto a compuestos organicos. - Google Patents

Mejoras en o con respecto a compuestos organicos.

Info

Publication number
MX2019009711A
MX2019009711A MX2019009711A MX2019009711A MX2019009711A MX 2019009711 A MX2019009711 A MX 2019009711A MX 2019009711 A MX2019009711 A MX 2019009711A MX 2019009711 A MX2019009711 A MX 2019009711A MX 2019009711 A MX2019009711 A MX 2019009711A
Authority
MX
Mexico
Prior art keywords
relating
organic compounds
molecular weight
acetylation
kda
Prior art date
Application number
MX2019009711A
Other languages
English (en)
Inventor
Reynaud Romain
Lovchik Martin
Brunner Gerhard
Scandolera Amandine
Original Assignee
Givaudan Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Givaudan Sa filed Critical Givaudan Sa
Publication of MX2019009711A publication Critical patent/MX2019009711A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/594—Mixtures of polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Una composición de cuidado de la piel que comprende ácido hialurónico acetilado de bajo peso molecular o su sal de sodio que tiene un peso molecular promedio en peso menor que 50kDa, y un grado de acetilación de al menos 3.6 es útil en el tratamiento de efecto visible de la edad en piel humana.
MX2019009711A 2017-03-10 2018-03-08 Mejoras en o con respecto a compuestos organicos. MX2019009711A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1703850.6A GB201703850D0 (en) 2017-03-10 2017-03-10 Improvements in or relating to organic compounds
PCT/EP2018/055823 WO2018162672A1 (en) 2017-03-10 2018-03-08 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
MX2019009711A true MX2019009711A (es) 2019-10-02

Family

ID=58605525

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019009711A MX2019009711A (es) 2017-03-10 2018-03-08 Mejoras en o con respecto a compuestos organicos.

Country Status (12)

Country Link
US (2) US20210128442A1 (es)
EP (1) EP3592330A1 (es)
JP (2) JP7295802B2 (es)
KR (2) KR20190122784A (es)
CN (1) CN110392565A (es)
AU (1) AU2018232835B2 (es)
CO (1) CO2019008987A2 (es)
GB (1) GB201703850D0 (es)
IL (1) IL268682B (es)
MX (1) MX2019009711A (es)
SG (1) SG11201907441WA (es)
WO (1) WO2018162672A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3104987B1 (fr) 2019-12-18 2023-06-30 Lvmh Rech Composition cosmétique comprenant de l’acide 2-glucoside ascorbique et de l’acide hyaluronique acétylé ou l’un de ses sels
CN111297727A (zh) * 2019-12-25 2020-06-19 华熙生物科技股份有限公司 一种美塑治疗组合物及其应用
CN115884744A (zh) * 2020-04-20 2023-03-31 莱雅公司 用于护理皮肤的组合物
CN113509442A (zh) * 2021-06-21 2021-10-19 浙江宜格企业管理集团有限公司 一种含补骨脂酚的脂质体及其制备方法
FR3130138A1 (fr) 2021-12-10 2023-06-16 L V M H Recherche Composition de lissage de la peau et/ou des lèvres
CN114191331B (zh) * 2021-12-10 2023-07-07 华熙生物科技股份有限公司 抗皮肤衰老组合物及其用途和抗皮肤衰老产品

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3142415B2 (ja) * 1992-04-21 2001-03-07 株式会社資生堂 高アセチル化率ヒアルロン酸及びその製造方法
US5679657A (en) * 1994-08-11 1997-10-21 Shiseido Co., Ltd. Low molecular weight acetylhyaluronate, skin-softening composition, method of manufacturing the same, and method of purifying the same
JP3556975B2 (ja) * 1994-08-11 2004-08-25 株式会社資生堂 アセチル化ヒアルロン酸の製造方法及び精製方法
JP3557044B2 (ja) * 1995-06-29 2004-08-25 株式会社資生堂 皮膚柔軟化剤
JPH10265332A (ja) * 1997-03-26 1998-10-06 Shiseido Co Ltd 水中油型乳化組成物
JPH10279425A (ja) * 1997-03-31 1998-10-20 Shiseido Co Ltd 皮膚外用剤
JP3634112B2 (ja) * 1997-03-31 2005-03-30 株式会社資生堂 皮膚外用剤
JP3667490B2 (ja) * 1997-03-31 2005-07-06 株式会社資生堂 皮膚外用剤
JP3667491B2 (ja) * 1997-03-31 2005-07-06 株式会社資生堂 皮膚外用剤
JPH10279426A (ja) * 1997-03-31 1998-10-20 Shiseido Co Ltd 皮膚外用剤
JPH10279418A (ja) * 1997-03-31 1998-10-20 Shiseido Co Ltd 皮膚外用剤
JP3634113B2 (ja) * 1997-03-31 2005-03-30 株式会社資生堂 皮膚外用剤
CH692919A5 (fr) * 1999-01-28 2002-12-13 Trb Chemedica S A Procédé de purification de l'acide hyaluronique à poids moléculaire élevé.
JP2004262777A (ja) 2003-02-27 2004-09-24 Shiseido Co Ltd アセチル化ヒアルロン酸含有眼用医薬組成物
JP2005068073A (ja) * 2003-08-25 2005-03-17 Takashi Fukazawa 目元用化粧料
JP2006306842A (ja) * 2005-03-30 2006-11-09 Kose Corp 二層型紫外線防御化粧料
EP2337544A2 (en) * 2007-04-30 2011-06-29 Living Proof, Inc. Use of matrix metalloproteinase inhibitors in skin care
JP2008280430A (ja) * 2007-05-10 2008-11-20 Mitsubishi Rayon Co Ltd ヒアルロン酸の製造方法
EP2033689A1 (en) * 2007-08-22 2009-03-11 Italfarmacia S.r.l. Injectable dermatological composition for treatment of the wrinkles
JP4781464B2 (ja) * 2009-12-21 2011-09-28 株式会社 資生堂 シート状化粧料
JP6071123B2 (ja) * 2012-02-10 2017-02-01 株式会社 資生堂 水中油型乳化皮膚化粧料
ITMI20121184A1 (it) * 2012-07-05 2014-01-06 Altergon Italia Srl Processo per la produzione industriale di ialuronato di sodio (hana) altamente purificato a peso molecolare controllato
KR20150015209A (ko) * 2013-07-31 2015-02-10 주식회사 피코테라 저분자 아세틸화 히알루론산의 제조방법 및 이의 용도
CN106109296B (zh) * 2016-06-30 2018-02-09 彭燕辉 一种保湿精华水及其制备方法
CN106176286B (zh) * 2016-08-30 2019-05-28 华熙生物科技股份有限公司 透明质酸皮肤护理膜及制备方法和应用

Also Published As

Publication number Publication date
SG11201907441WA (en) 2019-09-27
US11766393B2 (en) 2023-09-26
IL268682A (en) 2019-10-31
JP2023156270A (ja) 2023-10-24
RU2019128243A3 (es) 2021-05-11
CO2019008987A2 (es) 2020-01-17
BR112019017224A2 (pt) 2020-04-14
WO2018162672A1 (en) 2018-09-13
US20210128442A1 (en) 2021-05-06
AU2018232835B2 (en) 2024-01-18
EP3592330A1 (en) 2020-01-15
RU2019128243A (ru) 2021-04-12
US20210369592A1 (en) 2021-12-02
JP2020510034A (ja) 2020-04-02
IL268682B (en) 2022-07-01
KR20190122784A (ko) 2019-10-30
CN110392565A (zh) 2019-10-29
JP7295802B2 (ja) 2023-06-21
GB201703850D0 (en) 2017-04-26
AU2018232835A1 (en) 2019-09-05
KR20240064056A (ko) 2024-05-10

Similar Documents

Publication Publication Date Title
MX2019009711A (es) Mejoras en o con respecto a compuestos organicos.
MX2016014050A (es) Combinacion de un acido hialuronico y un polisacarido sulfatado.
MX2013005398A (es) Hidrolizado de colageno para usarse para mejorar la salud de la piel, el cabello y/o uñas de un humano.
BR112013026032A2 (pt) composições nutricionais incluindo ácidos graxos de cadeia ramificada para cicatrização de ferida
CY1124718T1 (el) Ανθεκτικο στη διασπαση υαλουρονικο χαμηλου μοριακου βαρους με σταυροδεσμους
RU2020123728A (ru) Композиции гиалуроновой кислоты с высокоэластичными свойствами и способы их применения
BR112015013774A2 (pt) membrana de hidrogel para prevenção de adesão
BR112014015940A8 (pt) composição de novo fármaco de carboidrato para tratamento de doenças humanas
JP2011522879A5 (es)
IN2014MN01056A (es)
FR2978665B1 (fr) Composition antiseptique
BR112013004436A2 (pt) composições e usos de materiais com atividade microbicida alta e toxicidade baixa
TN2015000520A1 (en) Pharmaceutical compositions comprising collagen and sodium hyaluronate
UA117480C2 (uk) Лікування цукрового діабету за допомогою складу інсуліну тривалої дії
PH12019501469A1 (en) Compositions and methods for treating biofilms
CY1119431T1 (el) Τοπικη αντιμικροβιακη δερματολογικη συνθεση
BR112012024887A2 (pt) grânulos de quitosana, preenchedor, processo para preparar os grânulos de quitosana, kit e disposto de injeção
FR3064473B1 (fr) Ingredient protecteur de l'equilibre de la flore microbienne cutanee et/ou mucosale
WO2018231718A8 (en) Dermal filler
PH12020550050A1 (en) Novel acylated insulin analogues and uses thereof
HRP20210574T1 (hr) Hitozan s neionskim nabojem
MX2017009325A (es) Gel intestinal de levodopa y carbidopa y metodos de uso.
MA31505B1 (fr) Hydrogel de carboxyalkylamide de chitosan, sa preparation et son utilisation cosmetique et dermatologique
MX2022014577A (es) Gel intestinal de levodopa y carbidopa y metodos de uso.
MX2019003764A (es) Composicion acuosa derivada de agua de mar y de algas marinas.